These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 76845)

  • 1. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally.
    Nathan E; Pedersen SE
    Acta Paediatr Scand; 1980 Nov; 69(6):793-6. PubMed ID: 7211365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium studies in dialysis encephalopathy.
    Elliott HL; Macdougall AI
    Proc Eur Dial Transplant Assoc; 1978; 15():157-63. PubMed ID: 740662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible dialysis encephalopathy: role for aluminium-containing gels.
    Masselot JP; Adhemar JP; Jaudon MC; Kleinknecht D; Galli A
    Lancet; 1978 Dec 23-30; 2(8104-5):1386-7. PubMed ID: 82892
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
    Davison AM; Walker GS; Oli H; Lewins AM
    Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
    Cartier F; Allain P; Gary J; Chatel M; Menault F; Pecker S
    Nouv Presse Med; 1978 Jan; 7(2):97-102. PubMed ID: 652514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis encephalopathy: recovery after interruption of aluminium intake.
    Poisson M; Mashaly R; Lebkiri B
    Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
    [No Abstract]   [Full Text] [Related]  

  • 11. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
    Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 14. Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management.
    Rob PM; Niederstadt C; Reusche E
    CNS Drugs; 2001; 15(9):691-9. PubMed ID: 11580308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F; Monnier N; Reveillaud RJ
    Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1 alpha OH vitamin D3 increases plasma aluminium in haemodialysed patients taking Al (OH)3.
    Fournier A; Demontis R; Tahiri Y; Herve M; Moriniere P; Leflon A; Abdull-Massih Z; Atik H; Benelmouffok S
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():390-4. PubMed ID: 3991529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.
    Platts MM; Goode GC; Hislop JS
    Br Med J; 1977 Sep; 2(6088):657-60. PubMed ID: 902042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of aluminum in the etiopathogenesis of neurological disturbances].
    Kulczycki J
    Rocz Panstw Zakl Hig; 1993; 44(1):49-53. PubMed ID: 8235342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.